Related references
Note: Only part of the references are listed.Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis
Sivapriya Ramamoorthy et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Regulation of Estrogen Receptor alpha N-Terminus Conformation and Function by Peptidyl Prolyl Isomerase Pin1
Prashant Rajbhandari et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Phosphorylation by p38 Mitogen-Activated Protein Kinase Promotes Estrogen Receptor α Turnover and Functional Activity via the SCFSkp2 Proteasomal Complex
Shweta Bhatt et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Negative Regulation of the Stability and Tumor Suppressor Function of Fbw7 by the Pin1 Prolyl Isomerase
Sang-Hyun Min et al.
MOLECULAR CELL (2012)
ERα Phosphorylation at Y537 by Src Triggers E6-AP-ERα Binding, ERα Ubiquitylation, Promoter Occupancy, and Target Gene Expression
Jun Sun et al.
MOLECULAR ENDOCRINOLOGY (2012)
Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells
P. Khanal et al.
ONCOGENE (2012)
Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis
H-Z Chen et al.
ONCOGENE (2012)
Quantitative In Situ Measurement of Estrogen Receptor mRNA Predicts Response to Tamoxifen
Jennifer M. Bordeaux et al.
PLOS ONE (2012)
Phosphorylation of Estrogen Receptor α at Serine 118 Directs Recruitment of Promoter Complexes and Gene-Specific Transcription
Tamika T. Duplessis et al.
ENDOCRINOLOGY (2011)
Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor-Positive Breast Cancer
Chungyeul Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Standardization of Estrogen Receptor Measurement in Breast Cancer Suggests False-Negative Results Are a Function of Threshold Intensity Rather Than Percentage of Positive Cells
Allison W. Welsh et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Proline cis/trans-Isomerase Pin1 Regulates Peroxisome Proliferator-activated Receptor γ Activity through the Direct Binding to the Activation Function-1 Domain
Yoshito Fujimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Prolyl Isomerase Pin1 Induces LC-3 Expression and Mediates Tamoxifen Resistance in Breast Cancer
Gwang Mo Namgoong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Mitch Dowsett et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Elevated PIN1 expression by C/EBPα-p30 blocks C/EBPα-induced granulocytic differentiation through c-Jun in AML
J. A. Pulikkan et al.
LEUKEMIA (2010)
Repression of Estrogen Receptor alpha by CDK11p58 Through Promoting its UbiquitinProteasome Degradation
Yanlin Wang et al.
JOURNAL OF BIOCHEMISTRY (2009)
Pin1 Catalyzes Conformational Changes of Thr-187 in p27Kip1 and Mediates Its Stability through a Polyubiquitination Process
Qiaoyun Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Systematic Mapping of Posttranslational Modifications in Human Estrogen Receptor-α with Emphasis on Novel Phosphorylation Sites
Christian Atsriku et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Repression of ESR1 through Actions of Estrogen Receptor Alpha and Sin3A at the Proximal Promoter
Stephanie J. Ellison-Zelski et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT
Kristopher J. Stanya et al.
JOURNAL OF CELL BIOLOGY (2008)
Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor β
Nathalie Picard et al.
MOLECULAR ENDOCRINOLOGY (2008)
The prolyl isomerase PIN 1: a pivotal new twist in phosphorylation signalling and disease
Kun Ping Lu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Estrogen insensitivity in a model of estrogen receptor-positive breast cancer lymph node metastasis
Joshua Chuck Harrell et al.
CANCER RESEARCH (2007)
Prolyl cis-trans isomerization as a molecular timer
Kun Ping Lu et al.
NATURE CHEMICAL BIOLOGY (2007)
A functional serine 118 phosphorylation site in estrogen receptor-α is required for down-regulation of gene expression by 17β-estradiol and 4-hydroxytamoxifen
Jingwei Cheng et al.
ENDOCRINOLOGY (2007)
Differential regulation of estrogen receptor α turnover and transactivation by Mdm2 and stress-inducing agents
Vanessa Duong et al.
CANCER RESEARCH (2007)
Ligand-dependent transcription of estrogen receptor α is mediated by the ubiquitin ligase EFP
Ayako Nakajima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase
Catherine M. Eakin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression pro-filing study
Yun Gong et al.
LANCET ONCOLOGY (2007)
Post-translational modifications of steroid receptors
H. Faus et al.
BIOMEDICINE & PHARMACOTHERAPY (2006)
Estrogen receptor positive breast cancer metastasis: Altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes
Joshua Chuck Harrell et al.
CANCER RESEARCH (2006)
Altered target gene regulation controlled by estrogen receptor-α concentration
AM Fowler et al.
MOLECULAR ENDOCRINOLOGY (2006)
E6AP and calmodulin reciprocally regulate estrogen receptor stability
L Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
MUC1 oncoprotein stabilizes and activates estrogen receptor α
XL Wei et al.
MOLECULAR CELL (2006)
Lives and times of nuclear receptors
Elaine T. Alarid
MOLECULAR ENDOCRINOLOGY (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor α N terminus
CC Valley et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Decreased expression of E6-associated protein in breast and prostate carcinomas
XH Gao et al.
ENDOCRINOLOGY (2005)
Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis
G Wulf et al.
EMBO JOURNAL (2004)
Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor
Y Tateishi et al.
EMBO JOURNAL (2004)
Pin1 links the activities of c-Abl and p300 in regulating p73 function
F Mantovani et al.
MOLECULAR CELL (2004)
Increases in estrogen receptor-alpha concentration in breast cancer cells promote serine 118/104/106-independent AF-1 transactivation and growth in the absence of estrogen
AM Fowler et al.
FASEB JOURNAL (2004)
Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor α (ERα), differentially affect ERα extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells
V Marsaud et al.
MOLECULAR ENDOCRINOLOGY (2003)
Nuclear receptors: integration of multiple signalling pathways through phosphorylation
C Rochette-Egly
CELLULAR SIGNALLING (2003)
Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling
G Reid et al.
MOLECULAR CELL (2003)
How the ubiquitin-proteasome system controls transcription
M Muratani et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Regulation of estrogen receptor α-mediated transcription by a direct interaction with protein phosphatase 2A
Q Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Regulation of NF-kappa B signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA
A Ryo et al.
MOLECULAR CELL (2003)
The prolyl isomerase Pin1 in breast development and cancer
G Wulf et al.
BREAST CANCER RESEARCH (2003)
Estrogen receptor phosphorylation
DA Lannigan
STEROIDS (2003)
Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage
GM Wulf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Automated subcellular localization and quantification of protein expression in tissue microarrays
RL Camp et al.
NATURE MEDICINE (2002)
The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response
HW Zheng et al.
NATURE (2002)
Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes
YC Liou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Pin 1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC
A Ryo et al.
NATURE CELL BIOLOGY (2001)
Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1
GM Wulf et al.
EMBO JOURNAL (2001)
Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins
XZ Zhou et al.
MOLECULAR CELL (2000)
The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation
DM Lonard et al.
MOLECULAR CELL (2000)
Share Paper
